| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.68B | 18.01B | 15.82B | 14.79B | 13.10B | 11.16B |
| Gross Profit | 8.37B | 7.91B | 7.23B | 6.34B | 5.47B | 4.48B |
| EBITDA | 4.45B | 4.40B | 4.37B | 4.38B | 4.01B | 3.34B |
| Net Income | 2.17B | 2.03B | 2.12B | 1.91B | 1.70B | 920.60M |
Balance Sheet | ||||||
| Total Assets | 21.64B | 22.24B | 22.02B | 21.44B | 21.71B | 21.36B |
| Cash, Cash Equivalents and Short-Term Investments | 7.80B | 8.09B | 10.20B | 9.68B | 9.46B | 9.33B |
| Total Debt | 1.83B | 2.14B | 3.24B | 4.81B | 6.44B | 8.00B |
| Total Liabilities | 7.67B | 8.33B | 9.12B | 10.22B | 12.04B | 13.24B |
| Stockholders Equity | 13.96B | 13.91B | 12.90B | 11.22B | 9.66B | 8.13B |
Cash Flow | ||||||
| Free Cash Flow | -167.00M | 515.00M | 2.69B | 2.29B | 1.97B | 96.74M |
| Operating Cash Flow | 485.50M | 2.77B | 3.34B | 2.98B | 3.35B | 1.95B |
| Investing Cash Flow | -713.50M | -2.45B | -790.00M | -743.00M | -1.47B | -2.17B |
| Financing Cash Flow | -685.00M | -2.43B | -2.04B | -2.01B | -1.76B | 4.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥43.19B | 14.60 | ― | 1.95% | 16.36% | 38.48% | |
76 Outperform | ¥69.69B | 16.92 | ― | 2.22% | 5.92% | 20.63% | |
73 Outperform | ¥15.48B | 59.29 | ― | ― | 14.37% | -44.67% | |
67 Neutral | ¥246.02B | 29.55 | ― | 1.51% | 11.92% | 33.70% | |
62 Neutral | ¥281.28B | 21.92 | 15.93% | 0.72% | 20.06% | 17.89% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥27.18B | 14.57 | ― | 1.85% | 4.17% | -20.08% |